Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patients.

HIV medicine - 1 Jul 2012

Bedimo R, Kyriakides T, Brown S, Weidler J, Lie Y, Coakley E, Holodniy M

Abstract excerpt

OBJECTIVES: The aim of the study was to determine the prognostic value of HIV replication capacity (RC) for subsequent antiretroviral (ARV) treatment response in ARV-experienced patients. METHODS: RC and phenotypic resistance testing were performed at baseline and week 12 on plasma samples from patients randomized to undergo a 12-week ARV drug-free period (ARDFP) or initiate immediate salvage therapy (no-ARDFP...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Drug Therapy, Combination

Share to Predictive Value of Tests

Share to Salvage Therapy

Share to Viral Load

Share to Virus Replication

Source

Identifiers

PMID: 22276745
DOI: 10.1111/j.1468-1293.2011.00981.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patients.PMID 22276745Read ↗

Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure.Semantic proximity Read ↗

Only slight impact of predicted replicative capacity for therapy response prediction.Semantic proximity Read ↗

Resistance and replication capacity assays: clinical utility and interpretation.Semantic proximity Read ↗

Assessing predicted HIV-1 replicative capacity in a clinical setting.Semantic proximity Read ↗

The role of phenotyping and replication capacity in anti-HIV therapeutics.Semantic proximity Read ↗

Phenotypic testing predicts virological response in successive protease inhibitor-based regimens.Semantic proximity Read ↗

Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.Semantic proximity Read ↗

Higher CD4+T Cell Counts Associated with Low ViralpolReplication Capacity among Treatment‐Naive Adults in Early HIV‐1 InfectionSemantic proximity Read ↗

Differential impact of resistance-associated mutations to protease inhibitors and nonnucleoside reverse transcriptase inhibitors on HIV-1 replication capacity.Semantic proximity Read ↗

Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure.Semantic proximity Read ↗

Predictive value of HIV-1 protease genotype and virtual phenotype on the virological response to lopinavir/ritonavir-containing salvage regimens.Semantic proximity Read ↗

Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.